These analyses provide evidence that differential expression of risk genes (PICALM, ADAM10, MEF2D, CD46 and IRAK3) with AD contribute to immune activation, angiogenic and apoptosis-related transcriptomic vascular pathologies. This evidence concerns the gene ADAM10 and Alzheimer disease.